- Proton beam therapy is a more precise treatment that can better focus radiation on a cancer, reducing the side-effects of treatment.
- This leads to better cognitive function and fewer long-term side-effects among patients who receive proton therapy compared to X-ray (photon) treatment.
- Although proton therapy is more expensive to deliver than photon radiation, studies have shown long-term cost-effectiveness of proton beam therapy for medulloblastoma.
- In a study of more than 1,000 adults with other types of locally advanced cancer, proton therapy led to fewer unplanned hospitalizations.
Canadian patients need to travel for treatment
- Researchers in the U.K. estimate that up to 15 per cent of all patients with curable cancers may benefit from proton therapy.
- However, without a domestic facility, Canadians who need proton beam therapy must travel out-of-country to receive this medically necessary treatment for their cancer.
Patients who are able to travel out-of-country report high levels of stress and feelings of isolation. Many of these concerns would be reduced with a domestic, Canadian proton therapy facility.
Progress toward Canadian facilities
In 2016, Québec announced a partnership with a private health-care company to build a standalone proton therapy facility in Montréal.
- It is recognized that the per-patient cost to deliver proton therapy would be less if a Canadian facility were available.
- Canadian doctors and patients eagerly await the day when a cancer patient can receive this advanced treatment without travelling out of country.
- Having access to proton therapy would also allow Canadian researchers to collaborate globally in scientific studies.
Derek Tsang receives research grant funding from ACCESS (https://accessforkidscancer.ca), the Brain Tumour Foundation of Canada, and the US National Cancer Institute. Tsang also received travel funding from Mevion Medical Systems in 2022.